Assorted News from the Last Week:
New clinical trials open:
- Beat Childhood Cancer Research Consortium will evaluate whether the drug eflornithine (DFMO) can help prevent relapse and improve outcomes for patients with Ewing sarcoma and osteosarcoma.
- NexTgen will enroll up to 60 children and young people with solid tumors across the United States and United Kingdom to test a personalized CAR-T cell immunotherapy designed to help the immune system recognize and attack cancer cells.
AI helps identify childhood cancer survivors needing extra support.
An integrative molecular map of pediatric B-cell precursor acute lymphoblastic leukemia.
The National Cancer Institute (NCI) released a major update to the Childhood Cancer Data Initiative (CCDI) Hub, specifically targeting rare solid tumors. The hub now includes Metastatic Osteosarcoma Spatial Profiling data.
The SIOP African Congress 2026 met this week and speakers emphasized the critical role of partnerships across disciplines, institutions, and borders in driving progress for African children with cancer: Highlights.
Study explains the link between NDMA-contaminated water and childhood cancer.
When chemotherapy was too risky: How a 2-year-old survived rare blood cancer with precision treatment.
Upcoming Webinars, Online Opportunities, and Meetings:
Following the cancellation of the 2025 Childhood Cancer Data Initiative (CCDI) Symposium originally scheduled for last fall, NCI will inaugurate the CCDI Virtual Symposium Series in the coming weeks. Sessions will occur across multiple days in March and April. Click Here to Learn More and Register.
CAC2 hosts Logan G. Spector and Jonathan Eric Agin, as they share the latest research and practical insights to support earlier recognition and better outcomes for children on April 22 at noon ET. Click here to register.
The opening session of CureSearch 2026 PEDS on April 23 noon ET sets the foundation for the entire series by examining why pediatric cancer drug development is uniquely challenging, and why progress often looks different than in adult oncology. This session is titled “Realities of Pediatric Cancer Drug Development—What’s Different and Why It Matters.” Click here for more information and to register for any of the upcoming sessions.
Elevate Childhood Cancer, in partnership with the Kidney Cancer Association, will host the FIRST-ever Wilms Tumor Virtual Forum: Connecting Families and Experts on April 30, 2026. Click here for more information and to register.
11th International Nursing Conference on Child and Adolescent Cancer Survivorship in Philadelphia on April 30 and May 1. Click here for more information and to register.
Richi Foundation invites the public to the Carnival of Colors to celebrate, foster community, and enjoy being together from 11:00 am to 5:00 pm ET on May 2. Click here for more information and to register.
National Brain Tumor Society and volunteer advocates from across the country will come together in Washington, D.C., for Head to the Hill on May 3-5, 2026. Register today.
Started in 2017, the annual MIB Agents FACTOR conference brings together the leading researchers, clinicians, and surgeons, along with patient families and OsteoWarriors (survivors, patients, and siblings of OsteoWarriors and OsteoAngels) to Make It Better for those battling this disease. This year the meeting will be in Columbus, Ohio June 25-27. Click here for information and to register.
Past Recordings:
CAC2 Member Gwen Nichols (Blood Cancer United) discusses efforts to transform pediatric cancer care by addressing long-standing challenges in drug development for children, particularly in rare diseases like pediatric AML.
Take Action:
The EVAN Foundation is now accepting applications from high-risk childhood cancer survivors and patients for the 2026 Evan Lindberg & Erik Ludwinski College Scholarship Program. Students must be accepted into a 4-year undergraduate institution, enrolling in the fall of 2026, and demonstrate a need for financial assistance.
- Awards & Key Dates: Eight $10,000 scholarships will be awarded. Applications are accepted from March 15th to May 1st, with winners announced July 1st. Each winner will receive $2,500 in scholarship support their freshman year. Funding will be renewed annually (for a total of $10,000 over 4 years), if eligibility requirements are maintained.
- For More Information & To Apply Please Visit: Childhood Cancer Survivor Scholarship Information — The EVAN Foundation
- Contact: info@theevanfoundation.org
SUBSCRIBE
Sign up to receive a copy of CAC2’s free childhood cancer news digest in your inbox each week.
